While animal studies with exendin-4 and liraglutide suggest neuroprotective benefits, clinical evidence in humans, especially for neurodegenerative diseases like Alzheimers Disease and Parkinsons Disease is limited
B., Nowak, J., Skjaerbaek, C., Flyvbjerg, A., Andreassen, T
Retatrutide for Type 2 Diabetes: Secondary Benefits Retatrutide shows glucose-lowering effects alongside weight loss in phase 2 data, but it is not approved for type 2 diabetes treatment anywhere as of 2026
En todo caso, intentar a bajar de peso slo con medicamento, sin cambiar de estilo de vida, sin hacer deporte y sin dieta, no puede tener un resultado estable a largo plazo
Niacinamide supports cellular energy and overall metabolic health, potentially enhancing the effects of tirzepatide